• Envoy Medical will consolidate Class A common stock 1-for-10, effective at 12:01 a.m. Eastern Time on October 26, 2026.
• Split-adjusted trading begins at market open October 26 on the Nasdaq Capital Market under the unchanged symbol COCH.
• The reverse split aims to maintain compliance with Nasdaq’s $1 minimum bid price requirement.
• Fractional shares will be paid in cash; authorized shares and par value remain unchanged.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Envoy Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-112720), on October 27, 2026, and is solely responsible for the information contained therein.